retatrutide dosing in trials A Clinician's Guide to Retatrutide Dosage: a Guide -

In addition, a large-scale clinical study demonstrated that GLP-1 analogues could reduce the mortality of patients with prostate cancer and diabetes (19)

M., Brennan, A

If you spend any time on TikTok or in wellness corners of the internet, youve probably heard about the microdosing of GLP-1 medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro)

In a recent phase 2 randomized trial, 9 weeks of low-dose semaglutide in 48 outpatient participants with alcohol use disorder led to reductions in some but not all measures of alcohol use and craving

As of 2026, retatrutide is still in Phase 3 clinical trials (the TRIUMPH program) and has not yet received FDA approval